Literature DB >> 16750167

Medium-chain fatty acids undergo elongation before beta-oxidation in fibroblasts.

Patricia M Jones1, Yasmeen Butt, Bette Messmer, Richard Boriak, Michael J Bennett.   

Abstract

Although mitochondrial fatty acid beta-oxidation (FAO) is considered to be well understood, further elucidation of the pathway continues through evaluation of patients with FAO defects. The FAO pathway can be examined by measuring the 3-hydroxy-fatty acid (3-OHFA) intermediates. We present a unique finding in the study of this pathway: the addition of medium-chain fatty acids to the culture media of fibroblasts results in generation of 3-OHFAs which are two carbons longer than the precursor substrate. Cultured skin fibroblasts from normal and LCHAD-deficient individuals were grown in media supplemented with various chain-length fatty acids. The cell-free medium was analyzed for 3-OHFAs by stable-isotope dilution gas-chromatography/mass-spectrometry. Our finding suggests that a novel carbon chain-length elongation process precedes the oxidation of medium-chain fatty acids. This previously undescribed metabolic step may have important implications for the metabolism of medium-chain triglycerides, components in the dietary treatment of a number of disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16750167     DOI: 10.1016/j.bbrc.2006.05.107

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Pre-exercise medium-chain triglyceride application prevents acylcarnitine accumulation in skeletal muscle from very-long-chain acyl-CoA-dehydrogenase-deficient mice.

Authors:  Sonja Primassin; Sara Tucci; Diran Herebian; Annette Seibt; Lars Hoffmann; Frank ter Veld; Ute Spiekerkoetter
Journal:  J Inherit Metab Dis       Date:  2010-05-06       Impact factor: 4.982

2.  Mechanisms of octanoic acid potentiation of insulin secretion in isolated islets.

Authors:  Tingting Zhang; Pan Chen; Charles A Stanley; Toshinori Hoshi; Changhong Li
Journal:  Islets       Date:  2019-03-08       Impact factor: 2.694

Review 3.  Very long-chain acyl-CoA dehydrogenase (VLCAD-) deficiency-studies on treatment effects and long-term outcomes in mouse models.

Authors:  Sara Tucci
Journal:  J Inherit Metab Dis       Date:  2017-02-28       Impact factor: 4.982

4.  Neonatal Long-Chain 3-Ketoacyl-CoA Thiolase deficiency: Clinical-biochemical phenotype, sodium-D,L-3-hydroxybutyrate treatment experience and cardiac evaluation using speckle echocardiography.

Authors:  Annemarijne R J Veenvliet; Mark R Garrelfs; Floris E A Udink Ten Cate; Sacha Ferdinandusse; Simone Denis; Sabine A Fuchs; Marit Schwantje; Rosa Geurtzen; Annemiek M J van Wegberg; Marleen C D G Huigen; Leo A J Kluijtmans; Ronald J A Wanders; Terry G J Derks; Lonneke de Boer; Riekelt H Houtkooper; Maaike C de Vries; Clara D M van Karnebeek
Journal:  Mol Genet Metab Rep       Date:  2022-05-04

5.  Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Can Be Improved by Lowering Accumulation of Fatty Acid Oxidation Intermediates.

Authors:  Suzan J G Knottnerus; Isabella Mengarelli; Rob C I Wüst; Antonius Baartscheer; Jeannette C Bleeker; Ruben Coronel; Sacha Ferdinandusse; Kaomei Guan; Lodewijk IJlst; Wener Li; Xiaojing Luo; Vincent M Portero; Ying Ulbricht; Gepke Visser; Ronald J A Wanders; Frits A Wijburg; Arie O Verkerk; Riekelt H Houtkooper; Connie R Bezzina
Journal:  Int J Mol Sci       Date:  2020-04-08       Impact factor: 5.923

6.  Docosahexaenoate-enriched fish oil and medium chain triglycerides shape the feline plasma lipidome and synergistically decrease circulating gut microbiome-derived putrefactive postbiotics.

Authors:  Matthew I Jackson; Dennis E Jewell
Journal:  PLoS One       Date:  2020-03-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.